FWPAY — Forward Pharma A/S Share News
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Brief: Forward Pharma reports Q4 earnings per share $0.20
Brief: Forward Pharma intends to appeal decision in patent interference proceeding with Biogen
Biogen wins Tecfidera U.S. patent dispute with Forward Pharma
Brief: US Patent board rules for Biogen in Forward patent case
Brief: Forward Pharma appoints Claus Bo Svendsen as CEO
Brief: Forward Pharma receives $1.25 bln pursuant to settlement and license agreement with Biogen
Brief: Forward Pharma enters license agreement with 2 units of Biogen and other parties
Biogen profit drops 22 pct due to Tecfidera-related costs
Brief: FORWARD PHARMA AGREES TO ENTER INTO SETTLEMENT AND LICENSE AGREEMENT WITH BIOGEN
Biogen in $1.25 bln deal with Forward Pharma to protect MS drug
Brief: Biogen, Forward Pharma to enter into settlement and license agreement
Brief: Forward Pharma reports Q3 loss per share $0.23
Brief: Forward Pharma reports qtrly adj loss of per share $0.27
Brief: Forward pharma A/S Q1 earnings per share $0.12
Brief: Forward Pharma says Karen Smith, Duncan Moore appointed to board
Brief: Forward Pharma A/S Q4 loss per share $0.20
Brief: Forward Pharma posts Q3 loss $0.34/shr
Brief: Forward Pharma Q1 earnings per share $0.11
Brief: Forward Pharma says U.S. patent office declares interference between Co and Biogen regarding treatment of multiple sclerosis